TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/24 14:10 | 4/19/24 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Moss David J | FL | OT | CFO,Trea | P.ad | 150 | 8.32 | 0 | 18 | 1 | 1,268 | D | ||||||||||||||
3/20/23 08:02 | 3/17/23 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Moss David J | FL | OT | CFO,Trea | P | 16 | 6.43 | 0 | 3 | 0 | 1,250 | D | ||||||||||||||
5/31/22 06:08 | 5/26/22 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Moss David J | FL | OT | CFO,Trea | P.m | 69 | 6.42 | 0 | 11 | 1 | 1,248 | D | ||||||||||||||
11/4/21 16:00 | 11/3/21 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Moss David J | FL | OT | CFO,Trea | S | -21 | 20.00 | 0 | -1 | 0 | 1,219 | D | ||||||||||||||
10/29/21 16:01 | 10/27/21 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Moss David J | FL | OT | CFO,Trea | S | -42 | 20.00 | 0 | -2 | 0 | 1,220 | D | ||||||||||||||
10/26/21 16:31 | 10/22/21 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Moss David J | FL | OT | CFO,Trea | S.m | -23 | 20.00 | 0 | -1 | 0 | 1,222 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |